Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group

Author： Masuda Norikazu   Taguchi Tetsuya   Nakayama Takahiro   Shiba Eiichi   Watatani Masahiro   Kurebayashi Junichi   Takatsuka Yuichi   Sakamoto Junichi   Noguchi Shinzaburo  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.61, Iss.6, 2008-05, pp. : 989-995

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy - a phase I, dose-finding study

By Lortholary A.   Maillard P.   Delva R.   Boisdron-Celle M.   Perard D.   Vernillet L.   Besenval M.   Gamelin E.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1773-1780

Elsevier

Access to resources Recommend Favorite

Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 283-285

Informa Healthcare

Access to resources Recommend Favorite

Phase II Study of Capecitabine in Combination With Thalidomide in Patients With Metastatic Breast Cancer

By Burris Howard A.   Jones Suzanne F.   Shipley Dianna   Meluch Anthony A.   Greco F. Anthony   Barton John H.   Yardley Denise A.   Hainsworth John D.  

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 408-412

Informa Healthcare

Access to resources Recommend Favorite

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer

By Albanell Joan  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 43-44

Informa Healthcare

Access to resources Recommend Favorite

Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study

By Costanzo F.D.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 2, 1999-03 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite